92 related articles for article (PubMed ID: 1480469)
1. Characterization and localization of cis-diamminedichloro-platinum(II) adducts on a purified oligonucleotide containing the codons 12 and 13 of H-ras proto-oncogene.
Pillaire MJ; Villani G; Hoffmann JS; Mazard AM; Defais M
Nucleic Acids Res; 1992 Dec; 20(24):6473-9. PubMed ID: 1480469
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene.
Pillaire MJ; Margot A; Villani G; Sarasin A; Defais M; Gentil A
Nucleic Acids Res; 1994 Jul; 22(13):2519-24. PubMed ID: 8041613
[TBL] [Abstract][Full Text] [Related]
3. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
Corda Y; Anin MF; Leng M; Job D
Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
Hagemeister T; Linscheid M
J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
[TBL] [Abstract][Full Text] [Related]
5. Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.
Williams RT; Nalbandian JN; Tu A; Wang Y
Clin Chim Acta; 2013 May; 420():160-70. PubMed ID: 23266768
[TBL] [Abstract][Full Text] [Related]
6. A 32P-postlabelling assay for DNA adducts induced by cis-diamminedichloroplatinum(II).
Försti A; Hemminki K
Cancer Lett; 1994 Aug; 83(1-2):129-37. PubMed ID: 8062205
[TBL] [Abstract][Full Text] [Related]
7. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
8. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
Suo Z; Lippard SJ; Johnson KA
Biochemistry; 1999 Jan; 38(2):715-26. PubMed ID: 9888812
[TBL] [Abstract][Full Text] [Related]
9. A novel technique to assay adducts of DNA induced by anticancer agent cis-diamminedichloroplatinum(II).
Sharma M; Jain R; Isac TV
Bioconjug Chem; 1991; 2(6):403-6. PubMed ID: 1805936
[TBL] [Abstract][Full Text] [Related]
10. Mono- and bifunctional binding of cis-diamminedichloroplatinum(II) to dinucleotides.
Försti A; Laatikainen R; Hemminki K
Chem Biol Interact; 1987; 63(1):1-14. PubMed ID: 3477334
[TBL] [Abstract][Full Text] [Related]
11. Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.
Davies MS; Berners-Price SJ; Hambley TW
Inorg Chem; 2000 Dec; 39(25):5603-13. PubMed ID: 11151361
[TBL] [Abstract][Full Text] [Related]
12. Reaction of (1R,2S,3S)-3-methylcyclohexanediamineplatinum(II) with DNA: isolation and characterization of the platinum-nucleotide adducts by means of HPLC and NMR spectroscopy.
Inagaki K; Sawaki K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):183-8. PubMed ID: 7728926
[TBL] [Abstract][Full Text] [Related]
13. DNA oligonucleotide duplexes containing intramolecular platinated cross-links: energetics, hydration, sequence, and ionic effects.
Kankia BI; Soto AM; Burns N; Shikiya R; Tung CS; Marky LA
Biopolymers; 2002 Nov; 65(3):218-27. PubMed ID: 12228927
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cisplatin adducts of oligonucleotides by fast atom bombardment mass spectrometry.
Martin LB; Schreiner AF; van Breemen RB
Anal Biochem; 1991 Feb; 193(1):6-15. PubMed ID: 2042743
[TBL] [Abstract][Full Text] [Related]
15. H8 chemical shifts in oligonucleotide cross-linked at a GpG sequence by cis-Pt(NH3)2(2+): a clue to the adduct structure.
Kozelka J; Fouchet MH; Chottard JC
Eur J Biochem; 1992 May; 205(3):895-906. PubMed ID: 1577007
[TBL] [Abstract][Full Text] [Related]
16. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
Gelasco A; Lippard SJ
Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303
[TBL] [Abstract][Full Text] [Related]
17. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene.
Hoffmann JS; Pillaire MJ; Maga G; Podust V; Hübscher U; Villani G
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5356-60. PubMed ID: 7777511
[TBL] [Abstract][Full Text] [Related]
19. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
20. Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.
Mellish KJ; Qu Y; Scarsdale N; Farrell N
Nucleic Acids Res; 1997 Mar; 25(6):1265-71. PubMed ID: 9092638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
